JP2008230974A - Hair-growing agent - Google Patents
Hair-growing agent Download PDFInfo
- Publication number
- JP2008230974A JP2008230974A JP2007068815A JP2007068815A JP2008230974A JP 2008230974 A JP2008230974 A JP 2008230974A JP 2007068815 A JP2007068815 A JP 2007068815A JP 2007068815 A JP2007068815 A JP 2007068815A JP 2008230974 A JP2008230974 A JP 2008230974A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- optionally substituted
- substituted lower
- chloro
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 210000004209 hair Anatomy 0.000 claims description 22
- -1 4 - (7- chloro -2 - [(E) -2- ( 2- chlorophenyl) vinyl] -4-quinolinyl) -N 1, N 1 - diethyl-1,4-pentanediamine Chemical compound 0.000 claims description 14
- CMLVHSVFSYNMGM-WYMLVPIESA-N 4-n-[7-chloro-2-[(e)-2-(2-chlorophenyl)ethenyl]quinolin-4-yl]-1-n,1-n-diethylpentane-1,4-diamine Chemical compound N=1C2=CC(Cl)=CC=C2C(NC(C)CCCN(CC)CC)=CC=1\C=C\C1=CC=CC=C1Cl CMLVHSVFSYNMGM-WYMLVPIESA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 6
- OVCDSSHSILBFBN-UHFFFAOYSA-N Amodiaquine Chemical compound C1=C(O)C(CN(CC)CC)=CC(NC=2C3=CC=C(Cl)C=C3N=CC=2)=C1 OVCDSSHSILBFBN-UHFFFAOYSA-N 0.000 claims description 5
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 claims description 5
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 claims description 5
- XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 claims description 4
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 229960001444 amodiaquine Drugs 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229960003677 chloroquine Drugs 0.000 claims description 3
- 229960000901 mepacrine Drugs 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 150000001555 benzenes Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229960004171 hydroxychloroquine Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000203 mixture Substances 0.000 abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 48
- 230000003779 hair growth Effects 0.000 description 23
- 238000013329 compounding Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000004359 castor oil Substances 0.000 description 9
- 235000019438 castor oil Nutrition 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 9
- 239000006210 lotion Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- MWEQTWJABOLLOS-UHFFFAOYSA-L disodium;[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate Chemical compound O.O.O.[Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP([O-])(=O)OP(O)([O-])=O)C(O)C1O MWEQTWJABOLLOS-UHFFFAOYSA-L 0.000 description 6
- 238000005342 ion exchange Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 229960005305 adenosine Drugs 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000003660 hair regeneration Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- QGXLVXZRPRRCRP-IDIVVRGQSA-L Adenosine 5'-phosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O QGXLVXZRPRRCRP-IDIVVRGQSA-L 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229960003720 enoxolone Drugs 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 2
- 229950003631 carpronium chloride Drugs 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000031774 hair cycle Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229950001046 piroctone Drugs 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PMUWWDBIGFMHAW-SJORKVTESA-N (2r,3r)-3-hydroxy-3-methyl-2-(4-methylphenyl)-2h-chromen-4-one Chemical compound C1=CC(C)=CC=C1[C@@H]1[C@](O)(C)C(=O)C2=CC=CC=C2O1 PMUWWDBIGFMHAW-SJORKVTESA-N 0.000 description 1
- 0 **1C=Cc2nc(*)c(*)c(N(*)*N(*)*)c2C=C1 Chemical compound **1C=Cc2nc(*)c(*)c(N(*)*N(*)*)c2C=C1 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- VQOSUVKMLOYCIS-UHFFFAOYSA-N C(C(O)C)(=O)O.C(CCCCCCCCCCCCC)OCCCCCCCCCC Chemical compound C(C(O)C)(=O)O.C(CCCCCCCCCCCCC)OCCCCCCCCCC VQOSUVKMLOYCIS-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000005103 alkyl silyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- UWKUITBHNDJYCO-UHFFFAOYSA-M sodium 2-(aminomethyl)tetradecanoate Chemical compound [Na+].CCCCCCCCCCCCC(CN)C([O-])=O UWKUITBHNDJYCO-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は新規育毛料を提供する。 The present invention provides a new hair growth material.
高齢化社会、ストレス社会といわれる現代社会では、頭部毛髪が様々な原因により、脱毛の危機にさらされる機会がますます多くなってきている。これに対応して、より優れた「育毛料」を提供すべく、様々な試みがなされている。 In the modern society, which is called an aging society and a stress society, the hair of the head is exposed to a risk of hair loss due to various causes. Corresponding to this, various attempts have been made to provide a better “hair growth material”.
育毛効果を発揮する薬剤としては、毛幹伸長を促進する作用をもつアデノシン等、末梢血管を拡張して血行を促進するビタミンE、塩化カルプロニウム、センブリエキス等、抗炎症効果、抗菌効果により頭皮を改善された状態に保つグリチルリチン誘導体、塩酸ジフェンヒドラミン、ヒノキチオール等、細胞賦活化作用を有するペンタデカン酸グリセリド、ニンジンエキス等、成長期を延長させるt−フラバノン等、男性型脱毛症や女性の壮年性脱毛症に有効なミノキシジル等がこれまでに知られ、その中には効能が優れることで商品化され、多用されているものもある。 Drugs that exhibit hair-growth effects include adenosine, which promotes hair shaft elongation, vitamin E that promotes blood circulation by expanding peripheral blood vessels, carpronium chloride, assembly extract, etc., and anti-inflammatory and antibacterial effects on the scalp Glycyrrhizin derivatives that maintain an improved state, diphenhydramine hydrochloride, hinokitiol, etc., pentadecanoic acid glycerides with cell activation activity, carrot extract, etc., t-flavanone etc. that prolongs the growth period, male pattern alopecia and female alopecia areata Minoxidil and the like which are effective in the past have been known, and some of them have been commercialized and frequently used due to their superior efficacy.
現在、薄毛の悩みをもつ多くの人の要望にさらに答えるため、より有効な育毛剤の開発が化粧品、医薬品業界をはじめとする各産業界において精力的に進められている。 Currently, in order to further respond to the demands of many people who have worries about thin hair, the development of more effective hair restorers is energetically advanced in various industries including the cosmetics and pharmaceutical industries.
本発明は、新規育毛料の提供を課題とする。 An object of the present invention is to provide a new hair growth material.
本発明者は、毛周期が休止期にあるマウスを用い、育毛活性を示す薬剤を見出すべく莫大な数の薬剤のスクリーニングを行なったところ、所定の化学構造を有する薬剤について育毛活性を示すことを見出し、本発明を完成するに至った。 The present inventor screened a huge number of drugs to find a drug exhibiting hair-growth activity using a mouse whose hair cycle is in a resting state, and found that a drug having a predetermined chemical structure exhibits hair-growth activity. The headline and the present invention have been completed.
詳しくは、本願は下記の発明を包含する。
(1)下記式(1)の化合物
R2は水素、任意的に置換された低級アルキル又は任意的に置換された低級アルケニルであるか、又は
R1及びR2はそれらが結合している炭素原子と一緒になって任意的に置換された不飽和の5〜6員環を形成してよく;
R3は水素又は任意的に置換された低級アルキルであり;
R4は任意的に置換された低級アルキルであり;
R5は任意的に置換された低級アルキルであり;
Xは水素又はハロゲン原子であり;
Aは任意的に置換又は任意的に置換されたベンゼン環が挿入された炭素数が2〜6の直鎖状アルキレン基である)
又はその化粧品学的に許容される塩を含んで成る、育毛料。
(2)前記化合物が
N4−(7−クロロ−2−[(E)−2−(2−クロロフェニル)ビニル]−4−キノリニル)−N1,N1−ジエチル−1,4−ペンタンジアミン(XIB4035)、
N4−(7−クロロ−4−キノリニル)−N1,N1−ジエチル−1,4−ペンタンジアミン(クロロキン)、
2−[[4−[(7−クロロ−4−キノリニル)アミノ]ペンチル]エチルアミノ]エタノール(ヒドロキシクロロキン)、
N4−(6−クロロ−2−メトキシ−9−アクリジニル)−N1,N1−ジエチル−1,4−ペンタンジアミン(キナクリン)及び
4−[(7−クロロ−4−キノリニル)アミノ]−2−[(ジエチルアミノ)メチル]フェノール(アモジアキン)
から成る群から選ばれる1又は複数種の化合物である、(1)の育毛料。
(3)上記式(1)の化合物又はその化粧品学的に許容される塩を配合した育毛量を頭皮に塗布することを含む、育毛方法。
(4)育毛料の製造ための、上記式(1)の化合物又はその化粧品学的に許容される塩の使用。
Specifically, this application includes the following inventions.
(1) Compound of the following formula (1)
R 2 is hydrogen, optionally substituted lower alkyl or optionally substituted lower alkenyl, or R 1 and R 2 are optionally substituted together with the carbon atom to which they are attached. Formed unsaturated 5-6 membered rings;
R 3 is hydrogen or optionally substituted lower alkyl;
R 4 is an optionally substituted lower alkyl;
R 5 is an optionally substituted lower alkyl;
X is a hydrogen or halogen atom;
A is a linear alkylene group having 2 to 6 carbon atoms into which an optionally substituted or optionally substituted benzene ring is inserted)
Or a hair restorer comprising a cosmetically acceptable salt thereof.
(2) the compound is N 4 - (7- chloro -2 - [(E) -2- ( 2- chlorophenyl) vinyl] -4-quinolinyl) -N 1, N 1 - diethyl-1,4-pentanediamine (XIB4035),
N 4 - (7- chloro-4-quinolinyl) -N 1, N 1 - diethyl-1,4-pentanediamine (chloroquine),
2-[[4-[(7-chloro-4-quinolinyl) amino] pentyl] ethylamino] ethanol (hydroxychloroquine),
N 4 - (6- chloro-2-methoxy-9-acridinyl) -N 1, N 1 - diethyl-1,4-pentanediamine (quinacrine) and 4 - [(7-chloro-4-quinolinyl) amino] - 2-[(Diethylamino) methyl] phenol (amodiaquine)
The hair restorer according to (1), which is one or more compounds selected from the group consisting of:
(3) A hair-growth method comprising applying to the scalp a hair-growth amount containing a compound of the above formula (1) or a cosmetically acceptable salt thereof.
(4) Use of the compound of the above formula (1) or a cosmetically acceptable salt thereof for the production of a hair restoration.
本発明は優れた育毛効果を発揮することのできる新規な育毛料組成物を提供する。 The present invention provides a novel hair-growth composition that can exhibit an excellent hair-growth effect.
本発明の内容を理解する上で、下記の用語の定義の参酌が役立つであろう。 In understanding the contents of the present invention, the following definitions of terms will be helpful.
用語の定義
「低級アルキル」とは、例えば1〜8個、好ましくは1〜5個、一般には1〜4個の炭素原子を直鎖または分岐鎖のアルキルを意味する。具体的には、メチル、エチル、n-プロピル、イソプロピル、n-ブチル、s-ブチル、イソブチル、t-ブチル、n-ペンチル、n-ヘキシルなどが挙げられる。
「低級アルケニル」とは、例えば2〜8個、好ましくは2〜5個、一般には2〜4個の炭素原子を直鎖または分岐鎖のアルケニルを意味する。具体的には、エテニル、アリル、2−メチルアリル、プロペニル、ブテニルなどが挙げられる。
式(1)の化合物におけるR1及びR2がそれらが結合している炭素原子と一緒になって形成する不飽和の5〜6員環には、限定することなく、シクロペンチル、シクロヘキシル、アリールであってよい。これらの環は1又は数個の置換基により置換されていてよく、そのような置換基としては例えばヒドロキシ、オキソ、アミド、シアノ、ハロゲン、低級アルキル、低級アルケニルなどが挙げられる。
低級アルキル、低級アルケニル又は低級アルキレンの任意的な置換基としては、限定することなく、ハロゲン、シアノ、C1~6アルキル、C1~6アルケニル、C1~6アルキニル、C1~6アルコキシ、C1~6アルキルカルボニル、C1~6アルコキシカルボニル、C1~6ハロアルコキシ、C1~6アルキルチオ、トリ(C1~4)アルキルシリル、C1~6アルキルアミノ、C1~6ジアルキルアミノ等が挙げられる。
「ハロゲン」にはフルオロ、クロロ、ブロモ、ヨードが含まれ、一般的にフルオロまたはクロロを意味する。
Definition of Terms “Lower alkyl” means a linear or branched alkyl having, for example, 1 to 8, preferably 1 to 5, and generally 1 to 4 carbon atoms. Specific examples include methyl, ethyl, n-propyl, isopropyl, n-butyl, s-butyl, isobutyl, t-butyl, n-pentyl, n-hexyl and the like.
“Lower alkenyl” means a straight or branched alkenyl having, for example, 2 to 8, preferably 2 to 5, and generally 2 to 4 carbon atoms. Specific examples include ethenyl, allyl, 2-methylallyl, propenyl, butenyl and the like.
Unsaturated 5- to 6-membered rings formed by R 1 and R 2 together with the carbon atom to which they are attached in the compound of formula (1) include, but are not limited to, cyclopentyl, cyclohexyl, aryl It may be. These rings may be substituted with one or several substituents, and examples of such substituents include hydroxy, oxo, amide, cyano, halogen, lower alkyl, and lower alkenyl.
Optional substituents for lower alkyl, lower alkenyl or lower alkylene include, but are not limited to, halogen, cyano, C 1-6 alkyl, C 1-6 alkenyl, C 1-6 alkynyl, C 1-6 alkoxy, C 1 ~ 6 alkyl carbonyl, C 1 ~ 6 alkoxycarbonyl, C 1 ~ 6 haloalkoxy, C 1 ~ 6 alkylthio, tri (C 1 ~ 4) alkylsilyl, C 1 ~ 6 alkyl amino, C 1 ~ 6 dialkylamino Etc.
“Halogen” includes fluoro, chloro, bromo, iodo and generally means fluoro or chloro.
一般式(1)で表される化合物の塩としては、特に限定されないが、例えば、無機塩として塩酸塩、硫酸塩、リン酸塩、臭化水素酸塩、ナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、アンモニウム塩等が挙げられる。有機塩としては、酢酸塩、乳酸塩、マレイン酸塩、フマル酸塩、酒石酸塩、クエン酸塩、メタンスルホン酸塩、p-トルエンスルホン酸塩、トリエタノールアミン塩、ジエタノールアミン塩、アミノ酸塩等が挙げられる。 Although it does not specifically limit as a salt of the compound represented by General formula (1), For example, hydrochloride, sulfate, phosphate, hydrobromide, sodium salt, potassium salt, magnesium salt as an inorganic salt, A calcium salt, an ammonium salt, etc. are mentioned. Organic salts include acetate, lactate, maleate, fumarate, tartrate, citrate, methanesulfonate, p-toluenesulfonate, triethanolamine salt, diethanolamine salt, amino acid salt, etc. Can be mentioned.
XIB4035及びその構造近縁化合物
本発明により育毛効果を有することを見出されたXIB4035はAISNEX社より市販されている。しかし、XIB4035と育毛との関係を示唆する報告は存在しない。また、XIB4035と同様、育毛効果を有することが見出され、XIB4035と構造が近縁するクロロキン、キナクリン及びアモジアキンは抗マラリア薬として知られる化合物である。これらもXIB4035と同様、育毛との関係を示唆する報告はされていない。
XIB4035 and its structurally related compounds XIB4035, which has been found to have a hair-growth effect according to the present invention, is commercially available from AISNEX. However, there are no reports suggesting a relationship between XIB4035 and hair growth. Similarly to XIB4035, chloroquine, quinacrine and amodiaquine, which are found to have a hair-growth effect and are closely related in structure to XIB4035, are compounds known as antimalarial drugs. Similar to XIB4035, there is no report suggesting a relationship with hair growth.
以下に上記化合物の構造及び物理化学的特性などを示す。
本発明に係る育毛料は育毛料に対して、式(1)の化合物を好ましくは0.1mM〜500mM、より好ましくは1mM〜100mM、更に好ましくは10mM〜50mMの量で含んで成る。式(1)の化合物の配合量が少なすぎると所期の効果が得られず、またその配合量が多すぎると効果が頭打ちと成り、不経済である。 The hair growth material according to the present invention comprises the compound of formula (1) in an amount of preferably 0.1 mM to 500 mM, more preferably 1 mM to 100 mM, and even more preferably 10 mM to 50 mM. If the compounding amount of the compound of formula (1) is too small, the desired effect cannot be obtained, and if the compounding amount is too large, the effect reaches a peak, which is uneconomical.
本発明の育毛料が採り得る剤型は、好ましくは外皮に適用可能な外用剤の剤型、例えば、液状、乳液状、クリーム状、エアゾール状等の剤型を選択することができる。また、本発明の育毛料の形態も任意であり、例えば、トニック、ヘアークリーム、ムース、シャンプー、リンス、乳液、化粧水、パック、エアゾール剤等の形態を採ることができる。本発明の育毛料は外皮に塗布して使用するのが特に好ましい。塗布方法は特に限定されるものではないが、例えば頭皮に1日1回以上、例えば1日1回から3回、塗布する皮膚面積に応じて適量、例えば1〜5ml塗布するのが好ましい。 As the dosage form that can be taken by the hair restorer of the present invention, a dosage form of an external preparation that can be applied to the outer skin, for example, a liquid form, an emulsion form, a cream form, an aerosol form, or the like can be selected. Moreover, the form of the hair restorer of this invention is also arbitrary, For example, forms, such as a tonic, a hair cream, a mousse, a shampoo, rinse, a milky lotion, a lotion, a pack, an aerosol agent, can be taken. It is particularly preferable to apply the hair growth material of the present invention to the outer skin. The application method is not particularly limited. For example, it is preferably applied to the scalp at least once a day, for example, 1 to 3 times a day, depending on the skin area to be applied, for example, 1 to 5 ml.
本発明の育毛料においては、必須成分である上記式(1)の化合物に加えて、必要に応じて、かつ本発明の所期の効果を損なわない限り、化粧品、医薬部外品、医薬品等において一般的に用いられる、各種の油性又は水性成分、保湿剤、増粘剤、防腐剤、酸化防止剤、香料、色剤、各種の薬剤等を配合することができる。 In the hair restorer of the present invention, in addition to the compound of the above formula (1), which is an essential component, cosmetics, quasi-drugs, pharmaceuticals, etc., if necessary and unless the desired effects of the present invention are impaired. Various oily or aqueous components, humectants, thickeners, preservatives, antioxidants, fragrances, colorants, various chemicals and the like that are generally used in can be used.
例えば、高級脂肪酸、固形パラフィン、流動パラフィン、シリコーン油、スクワラン、モノオレイン酸グリセリル、オリーブ油、イソプロピルミリステート、高級アルコール等の油分;グリセリン、ヒアルロン酸、プロピレングリコール、マルチトール、アテロコラーゲン、乳酸ナトリウム等の保湿剤;マルメロ粘質物、カルボキシビニルポリマー、キサンタンガム等の増粘剤;ニコチン酸アミド、ニコチン酸ベンジル、ビタミンEアセテート、センブリ抽出物、塩化カルプロニウム、アセチルコリン誘導体等の血管拡張剤;セリン、メチオニン、アルギニン等のアミノ酸類;ビタミンB6、ビタミンE類、ビオチン、パントテン酸類等のビタミン類;ニコチン酸、ニコチン酸メチル、ニコチン酸トコフェロール等のニコチン酸エステル類;セファランチン等の皮膚機能亢進剤;エストラジオール等の女性ホルモン剤;グリチルリチン酸、グリチルレチン酸、アズレン等の消炎剤;ヒノキチオール等の抗菌剤;メントール等の清涼剤;サリチル酸、亜鉛類、乳酸類等;クエン酸等の有機酸類を配合することができる。 For example, higher fatty acids, solid paraffin, liquid paraffin, silicone oil, squalane, glyceryl monooleate, olive oil, isopropyl myristate, higher alcohol, etc .; glycerin, hyaluronic acid, propylene glycol, maltitol, atelocollagen, sodium lactate, etc. Moisturizer; thickener such as quince mucilage, carboxyvinyl polymer, xanthan gum; vasodilator such as nicotinamide, benzyl nicotinate, vitamin E acetate, assembly extract, carpronium chloride, acetylcholine derivative; serine, methionine, arginine Amino acids such as vitamin B6, vitamin E, biotin, pantothenic acids and the like; nicotinic acid esters such as nicotinic acid, methyl nicotinate and tocopherol nicotinate; Skin function enhancers such as faranthin; female hormone agents such as estradiol; anti-inflammatory agents such as glycyrrhizic acid, glycyrrhetinic acid, and azulene; antibacterial agents such as hinokitiol; refreshing agents such as menthol; salicylic acid, zincs, lactic acids, etc .; citric acid Organic acids such as these can be blended.
また、本発明に係る式(1)の化合物以外の育毛作用が認められている、既知の育毛成分、例えばミノキシジル、サイクロ(登録商標)スポリン、アデノシン等を加えることにより、さらに効果的な育毛効果が本発明の育毛料において期待され得る。本発明の育毛料の具体的処方については、後述する。 Further, by adding a known hair-growth component other than the compound of formula (1) according to the present invention, for example, minoxidil, cyclo (registered trademark) sporin, adenosine, etc., a more effective hair-growth effect Can be expected in the hair restorer of the present invention. The specific prescription of the hair restorer of the present invention will be described later.
以下、実施例により、本発明をさらに具体的に説明するが、この実施例により、本発明の技術的範囲が限定的に解釈されるべきものではない。なお、以下の実施例等で、配合量を表す数値は、特に断わらない限り、配合される対象全体に対する質量%で表される。 EXAMPLES Hereinafter, although an Example demonstrates this invention further more concretely, the technical scope of this invention should not be limitedly interpreted by this Example. In addition, in the following examples etc., the numerical value showing a compounding quantity is represented by the mass% with respect to the whole object mix | blended unless there is particular notice.
育毛効果を有する薬剤のスクリーニング
マウス発毛試験
毛周期の休止期にあるC3H/HeSlcマウス(日本エス・エル・シー株式会社)を使用し、小川らの方法「ノーマル・アンド・アブノーマル・エピダーマル・ディファレンシエーション(Normal and Abnormal Epidermal Differentiation)、M. Seiji 及びI.A.Bernstein編集、第159〜170頁、1982年、東大出版)により行なった。
詳しくは、マウスの背部毛を約2×4cmの大きさに剃り、翌日より1日1回、0.1mlずつ連日試験薬剤を塗布し、毛再生が始まった部分の面積の変化を外観評価し、毛再生について調べた。各試験薬剤は70w/w%エタノールを溶媒とし、50mM及び100mMの濃度で試験した。各試料ともマウスを1群4匹とし、毛の再生面積の程度を評価した。30日後の毛再生の結果をそれぞれ4段階で評価した。4段階の基準は以下の表に示す。なお、比較対照として、薬剤未配合のものについても同様に操作・評価した。
Specifically, the back hair of the mouse is shaved to a size of about 2 × 4 cm, and the test drug is applied every day from the next day by 0.1 ml every day, and the appearance change of the area where hair regeneration has started is evaluated. The hair regeneration was examined. Each test agent was tested at a concentration of 50 mM and 100 mM using 70 w / w% ethanol as a solvent. Each sample had 4 mice per group, and the extent of hair regeneration area was evaluated. The results of hair regeneration after 30 days were evaluated in four stages. The four levels are shown in the table below. In addition, as a comparative control, the same operation / evaluation was carried out for the unmixed drug.
処方例1 乳液型養毛料の調製
(A相)
配合成分 配合量(質量%)
アデノシン5’−リン酸2ナトリウム 1.0
硬化ヒマシ油エチレンオキシド(60モル)付加物 2.0
グリセリン 10.0
ジプロピレングリコール 10.0
1, 3−ブチレングリコール 5.0
ポリエチレングリコール1500 5.0
Formulation Example 1 Preparation of emulsion type hair nourishing agent (phase A)
Compounding component amount (% by mass)
Adenosine 5'-disodium phosphate 1.0
Hardened castor oil ethylene oxide (60 mol) adduct 2.0
Glycerin 10.0
Dipropylene glycol 10.0
1,3-butylene glycol 5.0
Polyethylene glycol 1500 5.0
(B相)
配合成分 配合量(質量%)
セチルイソオクタネート 10.0
スクワラン 5.0
ワセリン 2.0
プロピルパラベン 2.0
(Phase B)
Compounding component amount (% by mass)
Cetyl isooctanoate 10.0
Squalane 5.0
Vaseline 2.0
Propylparaben 2.0
(C相)
配合成分 配合量(質量%)
カルボキシビニルポリマー1%水溶液 30.0
ヘキサメタリン酸ソーダ 0.03
イオン交換水 8.35
(Phase C)
Compounding component amount (% by mass)
Carboxyvinyl polymer 1% aqueous solution 30.0
Sodium hexametaphosphate 0.03
Ion exchange water 8.35
(D相)
配合成分 配合量(質量%)
イオン交換水 4.5
(Phase D)
Compounding component amount (% by mass)
Ion exchange water 4.5
(E相)
配合成分 配合量(質量%)
水酸化カリウム 0.12
イオン交換水 5.0
(Phase E)
Compounding component amount (% by mass)
Potassium hydroxide 0.12
Ion exchange water 5.0
<製造方法>
A相、B相をそれぞれ60℃で加熱溶解し、混合してホモミキサー処理してゲルを作った。これにD相を徐々に添加しホモミキサーで分散させた。
次にこれに、溶解したC相を加え、最後に溶解したE相を添加しホモミキサーで乳化してO/W乳液型の養毛料を得た。
<Manufacturing method>
The A phase and the B phase were heated and dissolved at 60 ° C., mixed and treated with a homomixer to form a gel. Phase D was gradually added thereto and dispersed with a homomixer.
Next, dissolved C phase was added to this, and finally dissolved E phase was added and emulsified with a homomixer to obtain an O / W emulsion type hair nourishing agent.
処方例2 クリーム状養毛料の調製
(A相)
配合成分 配合量(質量%)
流動パラフィン 5.0
セトステアリルアルコール 5.5
グリセリルモノステアレート 3.0
EO(20モル)−2−オクチルドデシルエーテル 3.0
プロピルパラベン 0.3
香料 0.1
Formulation Example 2 Preparation of creamy hair nourishing agent (phase A)
Compounding component amount (% by mass)
Liquid paraffin 5.0
Cetostearyl alcohol 5.5
Glyceryl monostearate 3.0
EO (20 mol) -2-octyldodecyl ether 3.0
Propylparaben 0.3
Fragrance 0.1
(B相)
配合成分 配合量(質量%)
アデノシン 5.0
グリセリン 8.0
ジプロピレングリコール 20.0
ポリエチレングリコール4000 5.0
ドデシル硫酸ナトリウム 0.1
ヘキサメタリン酸ソーダ 0.005
イオン交換水 残部
(Phase B)
Compounding component amount (% by mass)
Adenosine 5.0
Glycerin 8.0
Dipropylene glycol 20.0
Polyethylene glycol 4000 5.0
Sodium dodecyl sulfate 0.1
Sodium hexametaphosphate 0.005
Ion exchange water balance
<製造方法>
A相、B相をそれぞれ加熱溶解して混合し、ホモミキサーで乳化してクリーム状の養毛料を得た。
<Manufacturing method>
A phase and B phase were dissolved by heating and mixed, and emulsified with a homomixer to obtain a creamy hair nourishing agent.
処方例3 液状養毛料の調製(1)
配合成分 配合量(質量%)
アデノシン5’−リン酸カリウム 0.5
ステアリルジメチルアミンオキシド 0.5
硬化ヒマシ油エチレンオキシド(40モル)付加物 1.0
95%エタノール 54.0
イオン交換水 残部
Formulation Example 3 Preparation of liquid hair nourishment (1)
Compounding component amount (% by mass)
Adenosine 5′-potassium phosphate 0.5
Stearyl dimethylamine oxide 0.5
Hardened castor oil ethylene oxide (40 mol) adduct 1.0
95% ethanol 54.0
Ion exchange water balance
<製造方法>
95%エタノールにイオン交換水を加え、これに硬化ヒマシ油エチレンオキシド(40モル)付加物及びステアリルジメチルアミンオキシドを加えた後、アデノシン5’−リン酸カリウムを加え、撹拌溶解して、液状の養毛料を得た。
<Manufacturing method>
Add ion-exchanged water to 95% ethanol, add hydrogenated castor oil ethylene oxide (40 mol) adduct and stearyldimethylamine oxide, add adenosine 5'-potassium phosphate, dissolve with stirring, and dissolve in liquid form. Hair was obtained.
処方例4 液状養毛料の調製(2)
配合成分 配合量(質量%)
N−ヤシラウリル−β−アミノプロピオン酸ソーダ 0.2
アデノシン5’−リン酸2ナトリウム水和物 1.0
ドデシルベンゼンスルホン酸ナトリウム 0.5
硬化ヒマシ油エチレンオキシド(40モル)付加物 1.0
95%エタノール 54.0
イオン交換水 残部
Formulation Example 4 Preparation of liquid hair nourishing agent (2)
Compounding component amount (% by mass)
N-coconut lauryl-β-aminopropionic acid sodium salt 0.2
Adenosine 5′-phosphate disodium hydrate 1.0
Sodium dodecylbenzenesulfonate 0.5
Hardened castor oil ethylene oxide (40 mol) adduct 1.0
95% ethanol 54.0
Ion exchange water balance
<製造方法>
95%エタノールにイオン交換水を加え、これに硬化ヒマシ油エチレンオキシド(40モル)付加物,ドデシルベンゼンスルホン酸ナトリウム及びN−ヤシラウリル−β−アミノプロピオン酸ソーダを加えた後、アデノシン5’−リン酸2ナトリウム水和物を加え、撹拌溶解して、液状の養毛料を得た。
<Manufacturing method>
After adding ion-exchanged water to 95% ethanol, and adding hydrogenated castor oil ethylene oxide (40 mol) adduct, sodium dodecylbenzenesulfonate and sodium N-cocolauryl-β-aminopropionate, adenosine 5′-phosphate Disodium hydrate was added and dissolved by stirring to obtain a liquid hair nourishing agent.
処方例5 ローションの調製(1)
配合成分 配合量(質量%)
95%エタノール 55.0
アデノシン 0.02
グリチルレチン酸 0.001
オクトピロックス 0.2
1,3-ブチレングリコール 2.0
ポリオキシエチレン(60モル)硬化ヒマシ油 1.0
コハク酸 適量
香料および色素 適量
イオン交換水 残部
Formulation Example 5 Preparation of lotion (1)
Compounding component amount (% by mass)
95% ethanol 55.0
Adenosine 0.02
Glycyrrhetinic acid 0.001
Octopirox 0.2
1,3-butylene glycol 2.0
Polyoxyethylene (60 mol) hydrogenated castor oil 1.0
Succinic acid Appropriate fragrances and pigments Appropriate ionic water balance
<製造方法>
95%エタノールに、アデノシンを溶解させ、さらに、グリチルレチン酸、オクトピロックス、1,3-ブチレングリコール、ポリオキシエチレン(60モル)硬化ヒマシ油および香料を溶解させた(エタノール部)。次に、精製水に、コハク酸および色素を溶解させ、これを、前記エタノール部に加えた後、攪拌することにより、透明液状のローションを得た。
<Manufacturing method>
Adenosine was dissolved in 95% ethanol, and glycyrrhetinic acid, octopirox, 1,3-butylene glycol, polyoxyethylene (60 mol) hydrogenated castor oil and flavor were dissolved (ethanol part). Next, succinic acid and a pigment | dye were dissolved in purified water, and this was added to the said ethanol part, Then, it stirred and the transparent liquid lotion was obtained.
処方例6 ローションの調製(2)
配合成分 配合量(質量%)
95%エタノール 75.0
アデノシン5'−リン酸 0.0001
グリチルリチン酸ジカリウム 5.0
アラントイン 0.2
サリチル酸 0.01
ジプロピレングリコール 1.0
ポリオキシエチレン(24モル)・ポリオキシプロ ピレン(13モル) 0.5
デシルテトラデシルエーテル
乳酸 適量
乳酸ナトリウム 適量
香料および色素 適量
精製水 残量
Formulation Example 6 Preparation of Lotion (2)
Compounding component amount (% by mass)
95% ethanol 75.0
Adenosine 5′-phosphate 0.0001
Dipotassium glycyrrhizinate 5.0
Allantoin 0.2
Salicylic acid 0.01
Dipropylene glycol 1.0
Polyoxyethylene (24 mol), polyoxypropylene (13 mol) 0.5
Decyl tetradecyl ether
Lactic acid Appropriate amount Sodium lactate Appropriate amount of perfume and color
<製造方法>
95%エタノールに、アデノシン5'−リン酸を溶解させ、さらに、グリチルリチン酸ジカリウム、アラントイン、サリチル酸、ジプロピレングリコール、ポリオキシエチレン(24モル) ・ポリオキシプロピレン(13モル) デシルテトラデシルエーテルおよび香料を溶解させた(エタノール部)。次に、精製水に、乳酸、乳酸ナトリウムおよび色素を溶解させ、これを、前記エタノール部に加えた後、攪拌することにより、透明液状のローションを得た。
<Manufacturing method>
Adenosine 5'-phosphate is dissolved in 95% ethanol, and dipotassium glycyrrhizinate, allantoin, salicylic acid, dipropylene glycol, polyoxyethylene (24 mol), polyoxypropylene (13 mol) decyltetradecyl ether and flavor Was dissolved (ethanol part). Next, lactic acid, sodium lactate and a pigment were dissolved in purified water, added to the ethanol part, and then stirred to obtain a transparent liquid lotion.
処方例7 ローションの調製(3)
配合成分 配合量(質量%)
95%エタノール 60.0
アデノシン5'−リン酸2ナトリウムまたは 1.0
アデノシン5'−リン酸2カリウム
ボタンピエキス 0.2
メントール 0.5
酸化亜鉛 0.1
塩化ベンザルコニウム 0.2
セリン 0.05
ポリエチレングリコール400 1.0
ポリオキシエチレン(20モル)硬化ヒマシ油 1.0
リン酸 適量
香料および色素 適量
精製水 残量
Formulation Example 7 Preparation of lotion (3)
Compounding component amount (% by mass)
95% ethanol 60.0
Adenosine 5′-phosphate disodium or 1.0
Adenosine 5'-dipotassium phosphate
Button pi extract 0.2
Menthol 0.5
Zinc oxide 0.1
Benzalkonium chloride 0.2
Serine 0.05
Polyethylene glycol 400 1.0
Polyoxyethylene (20 mol) hydrogenated castor oil 1.0
Phosphoric acid
Perfume and pigment
Purified water remaining
<製造方法>
95%エタノールに、アデノシン5'−リン酸2ナトリウムまたはアデノシン5'−リン酸2カリウムを溶解させ、さらに、メントール、ボタンピエキス、セリン、ポリエチレングリコール400、ポリオキシエチレン(20モル)硬化ヒマシ油および香料を溶解させた(エタノール部)。次に、精製水に酸化亜鉛を分散させ、さらに、塩化ベンザルコニウム、リン酸および色素を溶解させ、これを、前記エタノール部に加えた後、攪拌することにより、2層状のローションを得た。
<Manufacturing method>
In 95% ethanol, adenosine 5'-disodium phosphate or adenosine 5'-dipotassium phosphate is dissolved, and menthol, button pi extract, serine, polyethylene glycol 400, polyoxyethylene (20 mol) hydrogenated castor oil and The fragrance was dissolved (ethanol part). Next, zinc oxide was dispersed in purified water, and further benzalkonium chloride, phosphoric acid and a dye were dissolved, and this was added to the ethanol portion, followed by stirring to obtain a two-layer lotion. .
本発明により優れた育毛効果を有する新規の育毛料が提供される。 The present invention provides a novel hair-growth material having an excellent hair-growth effect.
Claims (2)
R2は水素、任意的に置換された低級アルキル又は任意的に置換された低級アルケニルであるか、又は
R1及びR2はそれらが結合している炭素原子と一緒になって任意的に置換された不飽和の5〜6員炭素環を形成してよく;
R3は水素又は任意的に置換された低級アルキルであり;
R4は任意的に置換された低級アルキルであり;
R5は任意的に置換された低級アルキルであり;
Xは水素又はハロゲン原子であり;
Aは任意的に置換又は任意的に置換されたベンゼン環が挿入された炭素数が2〜6の直鎖状アルキレン基である)
又はその化粧品学的に許容される塩を含んで成る、育毛料。 Compound of the following formula (1)
R 2 is hydrogen, optionally substituted lower alkyl or optionally substituted lower alkenyl, or R 1 and R 2 are optionally substituted together with the carbon atom to which they are attached. Formed unsaturated 5-6 membered carbocycles;
R 3 is hydrogen or optionally substituted lower alkyl;
R 4 is an optionally substituted lower alkyl;
R 5 is an optionally substituted lower alkyl;
X is a hydrogen or halogen atom;
A is a linear alkylene group having 2 to 6 carbon atoms into which an optionally substituted or optionally substituted benzene ring is inserted)
Or a hair restorer comprising a cosmetically acceptable salt thereof.
N4−(7−クロロ−2−[(E)−2−(2−クロロフェニル)ビニル]−4−キノリニル)−N1,N1−ジエチル−1,4−ペンタンジアミン(XIB4035)、
N4−(7−クロロ−4−キノリニル)−N1,N1−ジエチル−1,4−ペンタンジアミン(クロロキン)、
2−[[4−[(7−クロロ−4−キノリニル)アミノ]ペンチル]エチルアミノ]エタノール(ヒドロキシクロロキン)、
N4−(6−クロロ−2−メトキシ−9−アクリジニル)−N1,N1−ジエチル−1,4−ペンタンジアミン(キナクリン)及び
4−[(7−クロロ−4−キノリニル)アミノ]−2−[(ジエチルアミノ)メチル]フェノール(アモジアキン)
から成る群から選ばれる1又は複数種の化合物である、請求項1記載の育毛料。 Wherein said compound is N 4 - (7- chloro -2 - [(E) -2- ( 2- chlorophenyl) vinyl] -4-quinolinyl) -N 1, N 1 - diethyl-1,4-pentanediamine (XIB4035) ,
N 4 - (7- chloro-4-quinolinyl) -N 1, N 1 - diethyl-1,4-pentanediamine (chloroquine),
2-[[4-[(7-chloro-4-quinolinyl) amino] pentyl] ethylamino] ethanol (hydroxychloroquine),
N 4 - (6- chloro-2-methoxy-9-acridinyl) -N 1, N 1 - diethyl-1,4-pentanediamine (quinacrine) and 4 - [(7-chloro-4-quinolinyl) amino] - 2-[(Diethylamino) methyl] phenol (amodiaquine)
The hair restorer according to claim 1, which is one or more compounds selected from the group consisting of:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007068815A JP2008230974A (en) | 2007-03-16 | 2007-03-16 | Hair-growing agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007068815A JP2008230974A (en) | 2007-03-16 | 2007-03-16 | Hair-growing agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008230974A true JP2008230974A (en) | 2008-10-02 |
Family
ID=39904214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007068815A Withdrawn JP2008230974A (en) | 2007-03-16 | 2007-03-16 | Hair-growing agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008230974A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009102570A2 (en) | 2008-02-12 | 2009-08-20 | Children's Medical Center Corporation | Treatments for neuropathy |
| JP2022041622A (en) * | 2020-09-01 | 2022-03-11 | 株式会社 資生堂 | Adenosine-containing composition and method for suppressing precipitation of adenosine |
-
2007
- 2007-03-16 JP JP2007068815A patent/JP2008230974A/en not_active Withdrawn
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009102570A2 (en) | 2008-02-12 | 2009-08-20 | Children's Medical Center Corporation | Treatments for neuropathy |
| JP2011511838A (en) * | 2008-02-12 | 2011-04-14 | チルドレンズ・メデイカル・センター・コーポレーシヨン | Neuropathy treatment |
| JP2022041622A (en) * | 2020-09-01 | 2022-03-11 | 株式会社 資生堂 | Adenosine-containing composition and method for suppressing precipitation of adenosine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110121330B (en) | Personal care compositions with glutathione precursors comprising 4-substituted resorcinols and amino acids | |
| JP7084567B2 (en) | Personal care composition comprising a glutathione precursor comprising nicotinamide and an amino acid | |
| JP2016020379A (en) | Photoaging inhibitor and skin thinning inhibitor | |
| CA2761732C (en) | Composition for preventing hair loss or for stimulating hair growth | |
| JP7300988B2 (en) | external composition | |
| CN110099672A (en) | Topical skin lightening additives and compositions with amino acid and nicotinamide compounds | |
| KR102006950B1 (en) | Cosmetics compositions for hair growth promoter | |
| JP4554805B2 (en) | Hair nourishing | |
| CN103442681B (en) | A kind of hair desquamation compositions containing pyridonium salt and allantoin | |
| JP3644809B2 (en) | External preparation for head | |
| TW201424764A (en) | Collagen stimulators and their use in the treatment of skin | |
| JP7082623B2 (en) | Composition for personal care with cystine | |
| JP2008230974A (en) | Hair-growing agent | |
| WO1998052516A1 (en) | Scalp care compositions | |
| JP5355913B2 (en) | Composition comprising retinoid and β-aminoisobutyric acid derivative | |
| EP2476408A1 (en) | External preparation containing pantethine phosphate ester | |
| US10406086B2 (en) | Moisturizer and cosmetic including the same | |
| JP3962166B2 (en) | Topical skin preparation | |
| JPH1179935A (en) | Anti-pigmentation agent, bleaching agent, and skin lotion for bleaching | |
| JPH1179937A (en) | Skin lotion for pimple treatment | |
| JP4327989B2 (en) | Hair cosmetics | |
| KR102084521B1 (en) | Compositions for prevention and improvement of acne | |
| WO2016085160A2 (en) | Composition for promoting hair growth or preventing hair loss | |
| JP2001335478A (en) | Skin care preparation | |
| JP4874686B2 (en) | Anti-wrinkle / improving agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20100601 |